CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds

SAN DIEGO–(BUSINESS WIRE)– #Biosynthesis–CB Therapeutics achieved the successful biosynthesis of psilocybin, psilocin and related tryptamine-based compounds and filed a patent on the process.